UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Immunotherapies Opdivo, Keytruda score high in real setting
by Kim Eun-young
2019-09-10 12:49
'Xarelto has superior renal preservation benefits in atrial fibrillation patients’
by Lee Han-soo
2019-09-09 16:54
Hanmi to unveil investigator-led P2 progress for cancer treatment
by Lee Han-soo
2019-09-09 15:47
Novo Nordisk's Ryzodeg leads Korean mixed insulin market
by Lee Han-soo
2019-09-09 14:18
PARP inhibitors to show intense rivalry at ESMO 2019
by Kim Yun-mi
2019-09-09 11:56
라인
Ildong to sell GSK’s influenza treatment
by Lee Han-soo
2019-09-06 17:02
Yuhan to expand biz scope to central nervous system disease
by Jeong Sae-im
2019-09-06 14:56
Seoul Pharmaceutical to export erectile dysfunction treatment to Taiwan
by Lee Han-soo
2019-09-05 17:04
Lilly’s migraine treatment Emgality lands in Korea
by Lee Hye-seon
2019-09-05 16:24
Daewoong, Medytox squabble over appraisal of additional spore for Nabota
by Lee Han-soo
2019-09-05 14:35
라인
[News analysis] Takeda Korea’s merger with Shire has to surmount big hurdle; labor union
by Lee Han-soo
2019-09-04 17:06
JW Pharmaceutical acquires Vietnamese drugmaker
by Lee Han-soo
2019-09-04 15:16
Takeda Korea vows to release 16 new drugs by 2023
by Kim Yun-mi
2019-09-03 15:40
SK goes global by developing new drugs, conducting CDMO biz
by Jeong Sae-im
2019-09-03 14:58
Hanmi, Daewoong among 20 innovative top-tier drugmakers in Asia Pacific
by Jeong Sae-im
2019-09-02 17:33
라인
Antidiabetic Forxiga proves efficacy in heart failure
by Kim Yun-mi
2019-09-02 11:35
Daewoong, Medytox differ in interpreting spore appraisal for Nabota
by Lee Han-soo
2019-08-30 16:26
Atopic dermatitis patients fall in despair as Dupixent may not get coverage soon
by Kim Yun-mi
2019-08-30 16:26
Doctors seem less eager to participate in ‘No-Japan’ campaign. Why?
by Lee Han-soo
2019-08-30 15:58
JW Pharmaceutical’s hyperlipidemia drug Livalo safe from diabetes risk
by Jeong Sae-im
2019-08-30 14:49
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top